Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review
Journal of Clinical Medicine · 25.05.2025 · 14 (11) · 3706
DOI: 10.3390/jcm14113706 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.05.2025. Verfasst von Loukia Pliouta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Center, 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mitochondria play a central role in energy metabolism and continuously adapt through dynamic processes such as fusion and fission. When the balance between these processes is disrupted, it can lead to mitochondrial dysfunction and increased oxidative stress, contributing to the development and progression of various cardiometabolic diseases (CMDs). Their role is crucial in diabetes mellitus (DM), since their dysfunction drives β-cell apoptosis, immune activation, and chronic inflammation through excessive ROS production, worsening endogenous insulin secretion. Moreover, sympathetic nervous system activation and altered dynamics, contribute to hypertension through oxidative stress, impaired mitophagy, endothelial dysfunction, and cardiomyocyte hypertrophy. Furthermore, the role of mitochondria is catalytic in endothelial dysfunction through excessive reactive oxygen species (ROS) production, disrupting the vascular tone, permeability, and apoptosis, while impairing antioxidant defense and promoting inflammatory processes. Mitochondrial oxidative stress, resulting from an imbalance between ROS/Reactive nitrogen species (RNS) imbalance, promotes atherosclerotic alterations and oxidative modification of oxidizing low-density lipoprotein (LDL). Mitochondrial DNA (mtDNA), situated in close proximity to the inner mitochondrial membrane where ROS are generated, is particularly susceptible to oxidative damage. ROS activate redox-sensitive inflammatory signaling pathways, notably the nuclear factor kappa B (NF-κB) pathway, leading to the transcriptional upregulation of proinflammatory cytokines, chemokines, and adhesion molecules. This proinflammatory milieu promotes endothelial activation and monocyte recruitment, thereby perpetuating local inflammation and enhancing atherogenesis. Additionally, mitochondrial disruptions in heart failure promote further ischemic injury and excessive oxidative stress release and impair ATP production and Ca2⁺ dysregulation, contributing to cell death, fibrosis, and decreased cardiac performance. This narrative review aims to investigate the intricate relationship between mitochondrial dysfunction and CMDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Diabetes Center, 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- 2nd Cardiology Department, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece.
- Endocrine Unit, 1st Department of Propaedeutic and Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- 3rd Department of Cardiology, "Sotiria" Thoracic Diseases Hospital of Athens, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Loukia Pliouta, Stamatios Lampsas, Aikaterini Kountouri, Emmanouil Korakas, John Thymis, Evangelos Oikonomou, Ignatios Ikonomidis
Zitieren
APA
Pliouta, L., Lampsas, S., Kountouri, A., Korakas, E., Thymis, J., Kassi, E., Oikonomou, E., Ikonomidis, I., & Lambadiari, V. (2025). Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review. Journal of Clinical Medicine, 14(11), 3706. https://doi.org/10.3390/jcm14113706
Vancouver
Pliouta L, Lampsas S, Kountouri A, Korakas E, Thymis J, Kassi E, et al. Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review. Journal of Clinical Medicine. 2025;14(11):3706. doi:10.3390/jcm14113706
BibTeX
@article{Pliouta2025,
author = {Pliouta, Loukia and Lampsas, Stamatios and Kountouri, Aikaterini and Korakas, Emmanouil and Thymis, John and Kassi, Eva and Oikonomou, Evangelos and Ikonomidis, Ignatios and Lambadiari, Vaia},
title = {Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {11},
pages = {3706},
doi = {10.3390/jcm14113706}
}
EUVIMED